These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 22352750)

  • 1. Clinical applications and biosafety of human adult mesenchymal stem cells.
    Mariani E; Facchini A
    Curr Pharm Des; 2012; 18(13):1821-45. PubMed ID: 22352750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential therapeutic applications of mesenchymal stromal cells.
    Larsen S; Lewis ID
    Pathology; 2011 Oct; 43(6):592-604. PubMed ID: 21876470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Potential of Mesenchymal Stem Cells in Immune-Mediated Diseases.
    Eljarrah A; Gergues M; Pobiarzyn PW; Sandiford OA; Rameshwar P
    Adv Exp Med Biol; 2019; 1201():93-108. PubMed ID: 31898783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease.
    Yañez R; Lamana ML; García-Castro J; Colmenero I; Ramírez M; Bueren JA
    Stem Cells; 2006 Nov; 24(11):2582-91. PubMed ID: 16873762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cells: properties and role in clinical bone marrow transplantation.
    Le Blanc K; Ringdén O
    Curr Opin Immunol; 2006 Oct; 18(5):586-91. PubMed ID: 16879957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical application of mesenchymal stem cells for hematological diseases].
    Taketani T
    Rinsho Ketsueki; 2018; 59(10):2362-2372. PubMed ID: 30305547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipose tissue-derived mesenchymal stem cells ameliorate bone marrow aplasia related with graft-versus-host disease in experimental murine models.
    Nishi Y; Murakami A; Murayama Y; Tsukahara N; Okamoto S; Nakachi S; Morichika K; Tamaki K; Noguchi H; Matsushita M; Karube KN; Fukushima T; Morishima S; Kishimoto H; Masuzaki H
    Transpl Immunol; 2019 Aug; 55():101205. PubMed ID: 30946889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance to Bone Marrow Transplantation: Do Mesenchymal Stromal Cells Still Have a Future for Acute or Chronic GvHD?
    Introna M; Golay J
    Front Immunol; 2020; 11():609063. PubMed ID: 33362797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cell-based therapy for autoimmune-related fibrotic skin diseases-systemic sclerosis and sclerodermatous graft-versus-host disease.
    Yang H; Cheong S; He Y; Lu F
    Stem Cell Res Ther; 2023 Dec; 14(1):372. PubMed ID: 38111001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of inflammatory diseases with mesenchymal stem cells.
    Newman RE; Yoo D; LeRoux MA; Danilkovitch-Miagkova A
    Inflamm Allergy Drug Targets; 2009 Jun; 8(2):110-23. PubMed ID: 19530993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal Stromal Cell Therapy for Chronic Lung Allograft Dysfunction: Results of a First-in-Man Study.
    Chambers DC; Enever D; Lawrence S; Sturm MJ; Herrmann R; Yerkovich S; Musk M; Hopkins PM
    Stem Cells Transl Med; 2017 Apr; 6(4):1152-1157. PubMed ID: 28186707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in diseases of the skeleton.
    Chanda D; Kumar S; Ponnazhagan S
    J Cell Biochem; 2010 Oct; 111(2):249-57. PubMed ID: 20506559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal Stromal Cells Stimulate the Proliferation and IL-22 Production of Group 3 Innate Lymphoid Cells.
    van Hoeven V; Munneke JM; Cornelissen AS; Omar SZ; Spruit MJ; Kleijer M; Bernink JH; Blom B; Voermans C; Hazenberg MD
    J Immunol; 2018 Aug; 201(4):1165-1173. PubMed ID: 29980610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
    Mauney JR; Volloch V; Kaplan DL
    Biomaterials; 2005 Nov; 26(31):6167-75. PubMed ID: 15913765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow mesenchymal cells: how do they contribute to tissue repair and are they really stem cells?
    Kuroda Y; Kitada M; Wakao S; Dezawa M
    Arch Immunol Ther Exp (Warsz); 2011 Oct; 59(5):369-78. PubMed ID: 21789625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential use of mesenchymal stem cells in hematopoietic stem cell transplantation.
    Kim EJ; Kim N; Cho SG
    Exp Mol Med; 2013 Jan; 45(1):e2. PubMed ID: 23306700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation.
    Le Blanc K; Ringdén O
    Biol Blood Marrow Transplant; 2005 May; 11(5):321-34. PubMed ID: 15846285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mesenchymal stem cell therapy in hematopoietic stem cell transplantation].
    Goto T; Murata M
    Rinsho Ketsueki; 2018; 59(2):195-204. PubMed ID: 29515075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trafficking and differentiation of mesenchymal stem cells.
    Liu ZJ; Zhuge Y; Velazquez OC
    J Cell Biochem; 2009 Apr; 106(6):984-91. PubMed ID: 19229871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current basic understanding and clinical application of mesenchymal stromal/stem cells].
    Miura Y
    Rinsho Ketsueki; 2018; 59(10):1935-1941. PubMed ID: 30305494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.